Related Experiment Video
Updated: Jul 11, 2026
07:00
A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene
Published on: April 1, 2019
Toll-like receptor 4 (TLR4) gene polymorphisms in celiac disease
I Santin1, A Castellanos-Rubio, I Hualde
1Endocrinology and Diabetes Research Group, Hospital de Cruces, Barakaldo, Bizkaia, Spain.
Tissue Antigens
|October 12, 2007
Summary
Toll-like receptor 4 (TLR4) gene variants were investigated for their association with celiac disease (CD). This study found no significant link between common TLR4 polymorphisms and CD development in the studied populations.
Area of Science:
- Immunology
- Genetics
- Gastroenterology
Background:
- Toll-like receptors (TLRs) are crucial for innate immunity, recognizing pathogen-associated molecular patterns.
- Coding variants in Toll-like receptor 4 (TLR4) have been linked to various autoimmune diseases.
- Celiac disease (CD) is an autoimmune disorder triggered by gluten ingestion.
Purpose of the Study:
- To investigate the association between specific Toll-like receptor 4 (TLR4) coding polymorphisms and celiac disease (CD).
- To determine if TLR4 gene variants influence susceptibility to CD.
Main Methods:
- Genotyping of two TLR4 coding single nucleotide polymorphisms (Asp299Gly and Thr399Ile).
- Study population included 95 CD family trios and 186 CD patients with 186 unrelated controls.
- Analysis of allele, genotype, and haplotype distributions and transmission disequilibrium.
Main Results:
- No significant differences were observed in allele, genotype, or haplotype frequencies between CD patients and controls.
- Transmission disequilibrium analysis showed no preferential transmission of specific TLR4 alleles to CD patients.
- The studied TLR4 polymorphisms (Asp299Gly and Thr399Ile) are not associated with CD in this cohort.
Conclusions:
- The findings do not support a role for the investigated TLR4 coding variants in the pathogenesis of celiac disease.
- Further research may be needed to explore other genetic factors or environmental triggers in CD development.
- This study contributes to understanding the genetic underpinnings of autoimmune gastrointestinal disorders.
Related Concept Videos
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:16Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
01:27Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...